PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30819230-13	2019	Finally, TRPM7 silencing attenuated the PI3K/AKT activation, which was enhanced by BAPTA-AM, MK886 or LY2904002 treatment in ovarian cancer cells.	MK-886	93-98	transient receptor potential cation channel subfamily M member 7	Homo sapiens	9-14	
20567598-3	2010	Here, we report the identification of the 5-lipoxygenase inhibitors, NDGA, AA861, and MK886, as potent blockers of the TRPM7 channel.	MK-886	86-91	transient receptor potential cation channel subfamily M member 7	Homo sapiens	119-124	
30819230-10	2019	Similar to that of TRPM7 silencing, treatment with MK886, a potent 5-lipoxygenase inhibitor to reduce TRPM7 expression, and/or BAPTA-AM, an intracellular calcium chelator, significantly mitigated the Epidermal growth factor (EGF) or Insulin-like growth factors (IGF)-stimulated migration, invasion, and the EMT in ovarian cancer cells by decreasing the levels of intracellular calcium [Ca2+]i.	MK-886	51-56	transient receptor potential cation channel subfamily M member 7	Homo sapiens	102-107